论文部分内容阅读
目的 探讨住院患儿各年龄组肺炎支原体肺炎 (MPP)发病情况及肺外并发症临床表现特点及疗效分析。方法 对 1999.7～ 2 0 0 0 .12住院肺炎患儿 90 4例 ,采用ELISA法进行血清特异性抗体测定。其中 93例阳性 ,按年龄分为三组 ,观察临床表现特点及肺外并发症 ,进行比较分析。结果 三组比较经统计学处理显示 :婴幼儿组发病数与儿童组无显著差异 ;婴幼儿临床表现以喘息呼吸困难、腹泻、心肌损害为多见 ;而胸腔积液婴儿组无一例发生 ,治疗仍首选红霉素。结论 婴幼儿MPP发病较过去报导明显增加 ,其临床喘息、呼吸困难发生率较高 ,对婴幼儿哮喘警惕支原体感染可能。婴幼儿组合并心肌损害 ,腹泻较多 ,应加以注意
Objective To investigate the incidence of Mycoplasma pneumoniae pneumonia (MPP) and the clinical features and efficacy of pulmonary complications in hospitalized children of all ages. Methods A total of 904 hospitalized children with pneumonia were admitted to our hospital from 1999.7 to 2000. Serum specific antibodies were detected by ELISA. 93 cases were positive, divided into three groups according to age, clinical features and extrahepatic complications were observed and compared. Results The results of the three groups showed that there was no significant difference in the incidence of infants and young children compared with the children. The clinical manifestations of infants and young children were wheezing dyspnea, diarrhea and myocardial damage were more common. However, none of the infants in the pleural effusion group were treated Erythromycin is still the first choice. Conclusion The incidence of MPP in infants and young children is obviously increased compared with the past reports. The incidence of clinical wheezing and dyspnea is high, so it is possible to be alert to mycoplasma infection in infants with asthma. Infants and young children combined with myocardial damage, diarrhea, should be noted